TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience-Reference-Cited by-同舟云学术

TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience

Published:2023-08-10 Issue:11 Volume:64 Page:1875-1879
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kenkre Vaishalee P.¹,Bradley Kristin²,Milton Arissa¹,Burkholder Joseph K.¹,Grindle Kreg¹,McMannes Jan¹,Kim KyungMann³,Callander Natalie¹,Juckett Mark⁴,Longo Walter⁵,Hematti Peiman¹⁵

Affiliation:

1. Division of Hematology, Oncology, Palliative Care, Department of Medicine, University of Wisconsin, Madison, WI, USA

2. Department of Human Oncology, University of Wisconsin, Madison, WI, USA

3. Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA

4. Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA

5. Medical College of Wisconsin, Milwaukee, WI, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2240918

Reference32 articles.

1. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.

2. Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma*

3. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma

4. Allogeneic transplantation for recurrent or refractory non-Hodgkin’s lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients;van Besien K;Biol Blood Marrow Transplant,1997

5. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma